News

News about advances made possible through IPIRA's work, such as innovations commercialized, campus partnerships with industry, and companies born out of licensing UC Berkeley intellectual property rights.

All News

November 13, 2025

Sensetics Raises $1.75M to Take Touch Sensing and Haptics into the Digital Age

link

November 12, 2025

Ansa Biotechnologies Sets New Standard in Long, Complex DNA

link

November 6, 2025

Travertine selected by Arianne for partnership on next-gen phosphate technology

link

Pow.Bio, Bühler, and ATV Technologies Scale Up Continuous Biomanufacturing Platform to 3,000 Liters

link

November 4, 2025

Azalea Therapeutics Launches with $82 Million Financing to Redefine Precision Genomic Medicines by Engineering Cells Directly Inside Each Patient

link

October 31, 2025

Strategic Radiology and InkSpace Imaging Partner to bring Flexible MR Coil Innovation to Independent Private Radiology Practices Nationwide

link

October 30, 2025

4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific

link

October 23, 2025

Generation Lab raises $11 million, becoming Accel’s first longevity bet

link

October 22, 2025

Ansa Biotechnologies Redefines What’s Possible in DNA Synthesis with 50 kb Sequence-Perfect Clonal Product

link

October 14, 2025

Gel nail manicures come with exposure to skin-damaging UV. A UC Berkeley chemist has a solution.

link

October 13, 2025

2025 Mayfield Divot AI List Honors Juvena Therapeutics Founder Dr. Hanadie Yousef for AI-Driven Drug Discovery Innovations

link

October 8, 2025

SirenOpt Awarded $2.4M by California Energy Commission

link

UC Berkeley’s Omar Yaghi shares 2025 Nobel Prize in Chemistry

link

October 7, 2025

Scribe Therapeutics CEO Benjamin Oakes Named to BioSpace 40 Under 40

link

October 6, 2025

AstraZeneca signs up to $555 million AI deal with Algen to develop therapies

link

October 2, 2025

Travertine starts operation of demonstration plant in Upstate New York

link

October 1, 2025

Ansa Biotechnologies Secures $54.4 Million in Series B Financing to Redefine How Scientists Access Synthetic DNA with Industry’s First Guaranteed On-Time Service

link

September 25, 2025

Magnetic Tides Awarded SBIR Grant from NIH National Institute of Mental Health

llink

September 24, 2025

ResVita Bio Announces Positive FDA Pre-IND Meeting, Advancing RVB-003 Toward IND Filing for Netherton Syndrome in Early 2026

link

September 19, 2025

Sift Biosciences Joins Plug and Play Accelerator Cohort 

link